Methylphenidate transdermal system in preschool children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 5, 2011, Pages 495-498

  Ghuman, Jaswinder Kaur ^a   Byreddy, Seenaiah ^a   Ghuman, Harinder Singh ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; IMIPRAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; CASE REPORT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CRYING; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG TOLERABILITY; FAMILY THERAPY; HUMAN; IRRITABILITY; LETTER; MALE; OPEN STUDY; PRESCHOOL CHILD; SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD, PRESCHOOL; HUMANS; MALE; METHYLPHENIDATE;

EID: 80155135908     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0049     Document Type: Letter

References (26)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
2. Barkley RA, Edwards G: Diagnostic interview, behavior rating scales, and the medical examination. In: Russell A. Barkley, ed. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Second ed. New York: The Guilford Press, 1998, pp. 263-293.
3. Beck M, Cataldo M, Slifer K, Pulbrook V, Ghuman J: Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills. Clin Pediatr (Phila) 44:515-526, 2005.
4. Edwards J: Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug?; December 7, 2009. Available at www.bnet.com/blog/ drug-business/shire- 8217s-daytrana-patch-recall-is-8th-so-far-timeto- pull-the-plug/3673. Accessed March 26, 2011.
5. Findling R, Bukstein O, Melmed R, Lopez F, Sallee F, Arnold L, Pratt R: A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:149-159, 2008.
6. Findling R, Wigal S, Bukstein O, Boellner S, Abikoff H, Turnbow J, Civil R: Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Clin Ther 31:1844-1855, 2009.
7. Frolich M, Giannotti A, Modell J: Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 93:647-648, 2001.
8. Ghuman J, Aman M, Lecavalier L, Riddle M, Gelenberg A, Wright R, Rice S, Ghuman H, Fort C: Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol 19:329-339, 2009.
9. Ghuman JK, Arnold LE, Anthony BJ: Psychopharmacological and other treatments in preschool children with ADHD: Current evidence and practice. J Child Adolesc Psychopharmacol 18:413-447, 2008.
10. Ghuman JK, Cataldo MD, Beck MH, Slifer KJ: Behavioral training for pill-swallowing difficulties in young children with autistic disorder. J Child Adolesc Psychopharmacol 14:601-611, 2004.
11. Ghuman JK, Ginsburg GS, Subramaniam G, Ghuman HS, Kau AS, Riddle MA: Psychostimulants in preschool children with attentiondeficit/ hyperactivity disorder: Clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry 40:516-524, 2001.
12. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284-1293, 2006.
13. Guy W: ECDEU Assessment Manual for Psychopharmacology (Revised). Washington, DC: Department of Health Education and Welfare, 1976.
14. Hull W: Heat-enhanced drug delivery: A survey paper. J Appl Res Clin Exp Ther 2:69-76, 2002.
15. Lord C, Rutter M, DiLavore P, Risi S: Autism Diagnostic Observation Schedule: ADOS: Manual. Los Angeles, CA: Western Psychological Services, 2002.
16. McDermott: FDA warns consumers not to use Triaminic vapor patch. FDA News 6-82, 2006.
17. Noven/Shire: Pharmacokinetics/pharmacodynamics summary NDA 21-514 24 October 2005: 1-43 Available at www.fda.gov/ohrms/ dockets/ac/05/briefing/2005- 4195B1-01-02-Noven-Appendix-1.pdf. Accessed March 26 2011.
18. Pappinen S, Urtti A: Microemulsions in topical drug delivery. In: EW Smith and HA Maibach, eds., Percutaneous Penetration Enhancers, Second Edition. Boca Raton, FL: Taylor & Francis Group, 2005, pp. 109-116.
19. Patrick K, Straughn A, Perkins J, Gonzalez M: Evolution of stimulants to treat ADHD: Transdermal methylphenidate. Hum Psychopharmacol 24:1-17, 2009.
20. Rutter M, LeCouteur A, Lord C: Autism Diagnostic Interview-Revised (ADI-R). Los Angeles, CA: Western Psychological Services, 2003.
21. Shaffer D, Gould M, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwalia S: A children's global assessment scale (C-GAS). Arch Gen Psychiatry 40:1228-1231, 1983.
22. Shire Pharmaceuticals Ireland Limited: Daytrana prescribing information. 2006.
23. Swanson JM: School-based Assessments and Interventions for ADD Students. Irvine, CA: KC Publishing, 1992.
24. Wagner M, Markowitz J, Patrick K: Methylphenidate ER tablet lodging in esophagus. J Am Acad Child Adolesc Psychiatry 40: 1244-1245, 2001.
25. Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCracken J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A: Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45:1294-1303, 2006.
26. Wilens T, Boellner S, Lopez F, Turnbow J, Wigal S, Childress A, Abikoff H, Manos M: Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 47:700-708, 2008.